Hantech Bio-Technology Co (ROCO:1294) Cash-to-Debt : 0.54 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Hantech Bio-Technology Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Hantech Bio-Technology Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.54.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Hantech Bio-Technology Co couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Hantech Bio-Technology Co's Cash-to-Debt or its related term are showing as below:

ROCO:1294' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.54 Med: 0.67 Max: 1.55
Current: 0.54

During the past 5 years, Hantech Bio-Technology Co's highest Cash to Debt Ratio was 1.55. The lowest was 0.54. And the median was 0.67.

ROCO:1294's Cash-to-Debt is ranked better than
51.55% of 1874 companies
in the Consumer Packaged Goods industry
Industry Median: 0.51 vs ROCO:1294: 0.54

Hantech Bio-Technology Co Cash-to-Debt Historical Data

The historical data trend for Hantech Bio-Technology Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Hantech Bio-Technology Co Cash-to-Debt Chart

Hantech Bio-Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

1.55

0.92

0.62

0.67

0.54

Hantech Bio-Technology Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial			0.62	0.74	0.67	1.20	0.54

Competitive Comparison of Hantech Bio-Technology Co's Cash-to-Debt

For the Packaged Foods subindustry, Hantech Bio-Technology Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hantech Bio-Technology Co's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Hantech Bio-Technology Co's Cash-to-Debt falls into.

Hantech Bio-Technology Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Hantech Bio-Technology Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	167.09	/	(6.631	+	300.456)
	=	0.54

Hantech Bio-Technology Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	167.09	/	(6.631	+	300.456)
	=	0.54

Hantech Bio-Technology Co (ROCO:1294) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Hantech Bio-Technology Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Hantech Bio-Technology Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hantech Bio-Technology Co (ROCO:1294) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hantech Bio-Technology Co Ltd (ROCO:1294) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 60, Section 1, Zhongshan Road, Yuanlin, TWN

Website

https://www.htbios.com

Hantech Bio-Technology Co Ltd provides health food customization services and most styles of patented aluminum foil bag packaging for Taiwan's health food manufacturers for liquids, jelly, and crystal jelly and others.

Hantech Bio-Technology Co (ROCO:1294) Headlines

No Headlines